Prognostic factors of adjuvant chemotherapy discontinuation among stage III colon cancer patients: A survey of medical oncologists and a systematic review and meta‐analysis - Boyne - 2020 - Cancer Medicine - Wiley Online Library
Cancers | Free Full-Text | Neo-Adjuvant Chemotherapy Reduces, and Surgery Increases Immunosuppression in First-Line Treatment for Ovarian Cancer
Current clinical practice and outcome of neoadjuvant chemotherapy for early breast cancer: analysis of individual data from 94,638 patients treated in 55 breast cancer centers,Journal of Cancer Research and Clinical Oncology -
What is AC-T or ACT Chemotherapy drug and what are its side effects? | OncoPower - YouTube
Validity of chemotherapy information derived from routinely collected healthcare data: A national cohort study of colon cancer patients - ScienceDirect
TECHNOLOGY
Cancer adjuvant chemotherapy strategic classification by artificial neural network with gene expression data: An example for non-small cell lung cancer - ScienceDirect
Cancer Treatments | Cancer Survivors | CDC
Time-dependent use of NACT and adjuvant treatments. ACT adjuvant... | Download Scientific Diagram
Association between adjuvant chemotherapy (ACT) and survival of stage... | Download Scientific Diagram
DFS according to adjuvant chemotherapy (ACT vs. NACT) | Download Scientific Diagram
Chemotherapy - Wikipedia
Combined homologous recombination repair deficiency and immune activation analysis for predicting intensified responses of anthracycline, cyclophosphamide and taxane chemotherapy in triple-negative breast cancer | BMC Medicine | Full Text
Activities aim to help patients pass the time during chemo
Osmosis from Elsevier on Twitter: "In chemotherapy, drugs are used to destroy cancer cells. Unfortunately, all these drugs can also act on healthy cells, resulting in serious side effects. Learn more about
Effect of adjuvant chemotherapy (ACT) on patient survival. ACT (+),... | Download Scientific Diagram
Dose-dense chemotherapy for breast cancer: what does the future hold? | Future Oncology
Clinical overview of metronomic chemotherapy in breast cancer | Nature Reviews Clinical Oncology
PARP inhibition in breast cancer: progress made and future hopes | npj Breast Cancer
Advanced Chemotherapy Technologies, Inc. Awarded $4 Million NIH Grant to Pursue Treatment for Locally Advanced Non-resectable Pancreatic Cancer | Business Wire
Broad Spectrum Chemo Therapy
TECHNOLOGY
